PMC:7271924 / 18667-18879 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T327","span":{"begin":32,"end":37},"obj":"SP_6;NCBITaxon:9606"},{"id":"T328","span":{"begin":38,"end":42},"obj":"UBERON:0001913"},{"id":"T329","span":{"begin":116,"end":124},"obj":"NCBITaxon:2"},{"id":"T330","span":{"begin":129,"end":140},"obj":"CHEBI:30808;CHEBI:30808"},{"id":"T331","span":{"begin":159,"end":172},"obj":"GO:0008283"},{"id":"T90222","span":{"begin":32,"end":37},"obj":"SP_6;NCBITaxon:9606"},{"id":"T78826","span":{"begin":38,"end":42},"obj":"UBERON:0001913"},{"id":"T31225","span":{"begin":116,"end":124},"obj":"NCBITaxon:2"},{"id":"T47845","span":{"begin":129,"end":140},"obj":"CHEBI:30808;CHEBI:30808"},{"id":"T96516","span":{"begin":159,"end":172},"obj":"GO:0008283"}],"text":"However, more than 90% of LF in human milk is in the form of apolactoferrin (160), which competes with siderophilic bacteria for ferric iron, and disrupts the proliferation of these microbial and other pathogens."}

{"project":"LitCovid-PubTator","denotations":[{"id":"443","span":{"begin":32,"end":37},"obj":"Species"},{"id":"450","span":{"begin":129,"end":140},"obj":"Chemical"}],"attributes":[{"id":"A443","pred":"tao:has_database_id","subj":"443","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"However, more than 90% of LF in human milk is in the form of apolactoferrin (160), which competes with siderophilic bacteria for ferric iron, and disrupts the proliferation of these microbial and other pathogens."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T204","span":{"begin":38,"end":42},"obj":"Body_part"}],"attributes":[{"id":"A204","pred":"fma_id","subj":"T204","obj":"http://purl.org/sig/ont/fma/fma62100"}],"text":"However, more than 90% of LF in human milk is in the form of apolactoferrin (160), which competes with siderophilic bacteria for ferric iron, and disrupts the proliferation of these microbial and other pathogens."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T38","span":{"begin":38,"end":42},"obj":"Body_part"}],"attributes":[{"id":"A38","pred":"uberon_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/UBERON_0001913"}],"text":"However, more than 90% of LF in human milk is in the form of apolactoferrin (160), which competes with siderophilic bacteria for ferric iron, and disrupts the proliferation of these microbial and other pathogens."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T242","span":{"begin":32,"end":37},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T243","span":{"begin":116,"end":124},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_2"}],"text":"However, more than 90% of LF in human milk is in the form of apolactoferrin (160), which competes with siderophilic bacteria for ferric iron, and disrupts the proliferation of these microbial and other pathogens."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T234","span":{"begin":26,"end":28},"obj":"Chemical"},{"id":"T235","span":{"begin":129,"end":140},"obj":"Chemical"},{"id":"T236","span":{"begin":136,"end":140},"obj":"Chemical"}],"attributes":[{"id":"A234","pred":"chebi_id","subj":"T234","obj":"http://purl.obolibrary.org/obo/CHEBI_73585"},{"id":"A235","pred":"chebi_id","subj":"T235","obj":"http://purl.obolibrary.org/obo/CHEBI_29034"},{"id":"A236","pred":"chebi_id","subj":"T236","obj":"http://purl.obolibrary.org/obo/CHEBI_18248"}],"text":"However, more than 90% of LF in human milk is in the form of apolactoferrin (160), which competes with siderophilic bacteria for ferric iron, and disrupts the proliferation of these microbial and other pathogens."}

{"project":"LitCovid-sentences","denotations":[{"id":"T149","span":{"begin":0,"end":212},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"However, more than 90% of LF in human milk is in the form of apolactoferrin (160), which competes with siderophilic bacteria for ferric iron, and disrupts the proliferation of these microbial and other pathogens."}

{"project":"MyTest","denotations":[{"id":"32574271-7359228-34514702","span":{"begin":77,"end":80},"obj":"7359228"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"However, more than 90% of LF in human milk is in the form of apolactoferrin (160), which competes with siderophilic bacteria for ferric iron, and disrupts the proliferation of these microbial and other pathogens."}

{"project":"TEST0","denotations":[{"id":"32574271-77-84-2882294","span":{"begin":77,"end":80},"obj":"[\"7359228\"]"}],"text":"However, more than 90% of LF in human milk is in the form of apolactoferrin (160), which competes with siderophilic bacteria for ferric iron, and disrupts the proliferation of these microbial and other pathogens."}

{"project":"2_test","denotations":[{"id":"32574271-7359228-34514702","span":{"begin":77,"end":80},"obj":"7359228"}],"text":"However, more than 90% of LF in human milk is in the form of apolactoferrin (160), which competes with siderophilic bacteria for ferric iron, and disrupts the proliferation of these microbial and other pathogens."}